Reliq Historical Income Statement

RHT Stock

CAD 0.22 0.00 0.00%

Historical analysis of Reliq Health income statement accounts such as Interest Expense of 42.6 K, Depreciation And Amortization of 275.9 K, Selling General Administrative of 12.1 M or Selling And Marketing Expenses of 594.9 K can show how well Reliq Health Technologies performed in making a profits. Evaluating Reliq Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Reliq Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Reliq Health Technologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Reliq Health Technologies is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reliq Health Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Reliq Income Statement Analysis

Reliq Health Technologies Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Reliq Health shareholders. The income statement also shows Reliq investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Reliq Health Income Statement Chart

At this time, Reliq Health's Cost Of Revenue is fairly stable compared to the past year. Net Interest Income is likely to climb to about 49.9 K in 2024, despite the fact that EBITDA is likely to grow to (6.9 M).

Other Operating Expenses Total Operating Expenses Interest Income

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Reliq Health Technologies. It is also known as Reliq Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Most accounts from Reliq Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Reliq Health Technologies current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reliq Health Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2020	2021	2023	2024 (projected)
Cost Of Revenue	604.2K	3.3M	3.7M	3.9M
Research Development	1.7M	2.2M	2.6M	1.7M

Cost Of Revenue Research Development

Reliq Health income statement Correlations

	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebitda	Total Operating Expenses	Net Income	Income Tax Expense	Interest Expense	Depreciation And Amortization	Selling General Administrative	Selling And Marketing Expenses	Ebit	Income Before Tax	Total Other Income Expense Net	Net Income From Continuing Ops	Research Development	Cost Of Revenue	Net Interest Income	Reconciled Depreciation	Interest Income
Total Revenue		1.0	0.82	-0.33	-0.36	0.73	-0.3	-0.25	0.62	0.19	0.73	0.77	-0.36	-0.31	0.34	-0.31	0.36	1.0	0.9	0.12	0.99
Gross Profit	1.0		0.81	-0.3	-0.33	0.71	-0.27	-0.26	0.61	0.19	0.71	0.75	-0.33	-0.29	0.33	-0.29	0.35	0.99	0.91	0.1	0.99
Other Operating Expenses	0.82	0.81		-0.62	-0.65	0.83	-0.55	-0.61	0.74	0.57	0.79	0.81	-0.64	-0.57	0.59	-0.57	0.69	0.83	0.63	0.58	0.8
Operating Income	-0.33	-0.3	-0.62		1.0	-0.88	0.99	0.13	-0.38	-0.06	-0.85	-0.65	1.0	0.99	-0.38	0.99	-0.79	-0.37	-0.16	-0.69	-0.22
Ebitda	-0.36	-0.33	-0.65	1.0		-0.89	0.98	0.17	-0.42	-0.1	-0.86	-0.67	1.0	0.99	-0.4	0.99	-0.79	-0.39	-0.18	-0.69	-0.25
Total Operating Expenses	0.73	0.71	0.83	-0.88	-0.89		-0.86	-0.18	0.57	0.1	0.99	0.85	-0.89	-0.87	0.42	-0.87	0.73	0.75	0.56	0.55	0.64
Net Income	-0.3	-0.27	-0.55	0.99	0.98	-0.86		0.02	-0.4	0.04	-0.85	-0.63	0.98	1.0	-0.23	1.0	-0.7	-0.34	-0.12	-0.61	-0.18
Income Tax Expense	-0.25	-0.26	-0.61	0.13	0.17	-0.18	0.02		-0.42	-0.93	-0.07	-0.25	0.15	0.05	-0.6	0.06	-0.51	-0.23	-0.22	-0.58	-0.33
Interest Expense	0.62	0.61	0.74	-0.38	-0.42	0.57	-0.4	-0.42		0.35	0.6	0.71	-0.4	-0.4	0.07	-0.39	0.19	0.62	0.32	0.19	0.59
Depreciation And Amortization	0.19	0.19	0.57	-0.06	-0.1	0.1	0.04	-0.93	0.35		0.0	0.13	-0.07	0.02	0.59	0.02	0.45	0.18	0.13	0.62	0.27
Selling General Administrative	0.73	0.71	0.79	-0.85	-0.86	0.99	-0.85	-0.07	0.6	0.0		0.85	-0.87	-0.86	0.33	-0.86	0.62	0.76	0.52	0.44	0.63
Selling And Marketing Expenses	0.77	0.75	0.81	-0.65	-0.67	0.85	-0.63	-0.25	0.71	0.13	0.85		-0.66	-0.63	0.38	-0.63	0.46	0.78	0.54	0.28	0.69
Ebit	-0.36	-0.33	-0.64	1.0	1.0	-0.89	0.98	0.15	-0.4	-0.07	-0.87	-0.66		0.99	-0.4	0.99	-0.79	-0.4	-0.19	-0.69	-0.25
Income Before Tax	-0.31	-0.29	-0.57	0.99	0.99	-0.87	1.0	0.05	-0.4	0.02	-0.86	-0.63	0.99		-0.26	1.0	-0.73	-0.35	-0.14	-0.64	-0.2
Total Other Income Expense Net	0.34	0.33	0.59	-0.38	-0.4	0.42	-0.23	-0.6	0.07	0.59	0.33	0.38	-0.4	-0.26		-0.27	0.65	0.35	0.29	0.6	0.35
Net Income From Continuing Ops	-0.31	-0.29	-0.57	0.99	0.99	-0.87	1.0	0.06	-0.39	0.02	-0.86	-0.63	0.99	1.0	-0.27		-0.73	-0.35	-0.14	-0.64	-0.2
Research Development	0.36	0.35	0.69	-0.79	-0.79	0.73	-0.7	-0.51	0.19	0.45	0.62	0.46	-0.79	-0.73	0.65	-0.73		0.38	0.38	0.84	0.34
Cost Of Revenue	1.0	0.99	0.83	-0.37	-0.39	0.75	-0.34	-0.23	0.62	0.18	0.76	0.78	-0.4	-0.35	0.35	-0.35	0.38		0.88	0.16	0.98
Net Interest Income	0.9	0.91	0.63	-0.16	-0.18	0.56	-0.12	-0.22	0.32	0.13	0.52	0.54	-0.19	-0.14	0.29	-0.14	0.38	0.88		0.08	0.93
Reconciled Depreciation	0.12	0.1	0.58	-0.69	-0.69	0.55	-0.61	-0.58	0.19	0.62	0.44	0.28	-0.69	-0.64	0.6	-0.64	0.84	0.16	0.08		0.11
Interest Income	0.99	0.99	0.8	-0.22	-0.25	0.64	-0.18	-0.33	0.59	0.27	0.63	0.69	-0.25	-0.2	0.35	-0.2	0.34	0.98	0.93	0.11

Click cells to compare fundamentals

Reliq Health Account Relationship Matchups

Reliq Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Revenue	181.9K	1.1M	1.5M	8.6M	9.8M	10.3M
Gross Profit	7.8K	174.4K	858.0K	5.3M	6.1M	6.4M
Other Operating Expenses	13.6M	12.3M	13.1M	16.8M	19.4M	20.3M
Operating Income	(13.9M)	(11.2M)	(11.6M)	(8.3M)	(7.5M)	(7.1M)
Ebitda	(13.3M)	(10.7M)	(11.5M)	(8.1M)	(7.3M)	(6.9M)
Total Operating Expenses	13.5M	11.3M	12.5M	13.6M	15.6M	16.4M
Net Income	(12.1M)	(11.2M)	(11.8M)	(8.0M)	(7.2M)	(6.9M)
Income Tax Expense	(893.3K)	36.2K	46.6K	(124.8K)	(143.5K)	(136.3K)
Depreciation And Amortization	445.4K	125.8K	191.9K	228.5K	262.8K	275.9K
Selling General Administrative	7.4M	8.8M	10.1M	10.0M	11.5M	12.1M
Selling And Marketing Expenses	274.5K	353.5K	515.7K	492.6K	566.5K	594.9K
Ebit	(13.9M)	(11.2M)	(11.6M)	(8.3M)	(7.5M)	(7.8M)
Income Before Tax	(13.0M)	(11.1M)	(11.8M)	(8.2M)	(7.4M)	(7.7M)
Total Other Income Expense Net	893.3K	43.6K	(153.5K)	124.8K	143.5K	150.7K
Net Income From Continuing Ops	(13.0M)	(11.1M)	(11.8M)	(8.2M)	(7.4M)	(7.7M)
Research Development	5.2M	1.7M	1.7M	2.2M	2.6M	1.7M
Cost Of Revenue	174.1K	968.7K	604.2K	3.3M	3.7M	3.9M
Net Income Applicable To Common Shares	(13.0M)	(11.1M)	(11.8M)	(8.2M)	(7.4M)	(7.7M)
Net Interest Income	0.0	(36.2K)	(46.6K)	41.3K	47.5K	49.9K
Reconciled Depreciation	634.2K	445.4K	125.8K	115.3K	132.6K	242.5K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Reliq Stock Analysis

When running Reliq Health's price analysis, check to measure Reliq Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reliq Health is operating at the current time. Most of Reliq Health's value examination focuses on studying past and present price action to predict the probability of Reliq Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reliq Health's price. Additionally, you may evaluate how the addition of Reliq Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Reliq Historical Income Statement

About Reliq Income Statement Analysis

Reliq Health Income Statement Chart

Other Operating Expenses

Total Operating Expenses

Interest Income

Reliq Health income statement Correlations

Reliq Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Reliq Health income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Reliq Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Ebitda	+ 1.0	Operating Income
Ebit	+ 1.0	Operating Income
Ebit	+ 1.0	Ebitda
Income Before Tax	+ 1.0	Net Income

Depreciation And Amortization	- 0.93	Income Tax Expense
Ebit	- 0.89	Total Operating Expenses
Total Operating Expenses	- 0.89	Ebitda
Total Operating Expenses	- 0.88	Operating Income
Ebit	- 0.87	Selling General Administrative
Net Income From Continuing Ops	- 0.87	Total Operating Expenses